Urea Cream 39%

Urea Cream 39%
SPL v3
SPL
SPL Set ID e79004b9-ffbc-3d06-e053-2995a90a8cd7
Route
TOPICAL
Published
Effective Date 2022-09-23
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Urea (390 mg)
Inactive Ingredients
Mineral Oil Petrolatum Propylene Glycol Water Glyceryl Monostearate Xanthan Gum Dimethyl Isosorbide Carbomer Interpolymer Type A (55000 Cps) Cetyl Alcohol Sodium Hydroxide

Identifiers & Packaging

Pill Appearance
Color: white
Marketing Status
UNAPPROVED DRUG OTHER Active Since 2022-09-23

Description

This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.


Medication Information

Warnings and Precautions

KEEP OUT OF REACH OF CHILDREN.

Dosage and Administration

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

Dosage Forms and Strengths

8 oz. (227 g) bottles, NDC 44523-801-08

Contraindications

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

Description

This product is a keratolytic emollient which is a gentle, yet potent, tissue softener for skin.

Each gram contains 390 mg of urea in a vehicle consisting of: carbomer, cetyl alcohol, dimethyl isosorbide, glyceryl stearate, mineral oil, petrolatum, propylene glycol, sodium hydroxide, water, and xanthan gum.

Urea is a diamide of carbonic acid with the following chemical structure:

Section 34076-0

Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or

elsewhere. Avoid contact with eyes, lips and mucous membranes.

Section 34080-2

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

Section 34083-6

Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

Section 34084-4

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

Section 34090-1

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

Section 42228-7

Category C.Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

Section 42229-5

To reporta serious adverse event or obtain product information, call (866) 762-2365.

Manufactured for:

BIOCOMP PHARMA, INC.

San Antonio, TX 78230 1355



2100669 [00] R1021

Section 42232-9

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Section 43682-4

The mechanism of action of topically applied urea is not yet known.

Section 44425-7

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to

temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

Section 51945-4

Notice:

Protect from freezing and excessive heat. Keep bottle tightly closed.

General:

This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

Indications:

This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.


Structured Label Content

Dosage and Administration (34068-7)

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

Dosage Forms and Strengths (34069-5)

8 oz. (227 g) bottles, NDC 44523-801-08

Contraindications (34070-3)

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

Warnings and Precautions (34071-1)

KEEP OUT OF REACH OF CHILDREN.

Section 34076-0 (34076-0)

Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or

elsewhere. Avoid contact with eyes, lips and mucous membranes.

Section 34080-2 (34080-2)

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

Section 34083-6 (34083-6)

Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

Section 34084-4 (34084-4)

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

Description (34089-3)

This product is a keratolytic emollient which is a gentle, yet potent, tissue softener for skin.

Each gram contains 390 mg of urea in a vehicle consisting of: carbomer, cetyl alcohol, dimethyl isosorbide, glyceryl stearate, mineral oil, petrolatum, propylene glycol, sodium hydroxide, water, and xanthan gum.

Urea is a diamide of carbonic acid with the following chemical structure:

Section 34090-1 (34090-1)

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

Section 42228-7 (42228-7)

Category C.Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

Section 42229-5 (42229-5)

To reporta serious adverse event or obtain product information, call (866) 762-2365.

Manufactured for:

BIOCOMP PHARMA, INC.

San Antonio, TX 78230 1355



2100669 [00] R1021

Section 42232-9 (42232-9)

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Section 43682-4 (43682-4)

The mechanism of action of topically applied urea is not yet known.

Section 44425-7 (44425-7)

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to

temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

Section 51945-4 (51945-4)

Notice: (NOTICE:)

Protect from freezing and excessive heat. Keep bottle tightly closed.

General: (GENERAL:)

This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

Indications: (INDICATIONS:)

This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)